Wednesday, September 19, 2018
 
 
Company News: Page (1) of 1 - 07/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Gastroparesis Treatment Market 2018 Global Trends, Share, Industry Size, Growth, Opportunities, and Industry Forecast to 2023

(July 12, 2018)


"Gastroparesis Treatment Market"
Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Global Gastroparesis Treatment Market Research Report- Forecast to 2023” Gives industry size, top players and worldwide demand

Market Synopsis of Gastroparesis Treatment Market:

Market Scenario:

Gastroparesis is a condition of delayed gastric emptying because of partial paralysis of the stomach, resulting in food remaining in the stomach for an abnormally long time. The gastric muscles contracts to move food down into the small intestine which is controlled by the vagus nerve. Damage to the vagus nerve or the muscles of the stomach and intestines causes food to move slowly resulting in Gastroparesis. Gastroparesis predominantly affects young adult females. Although Gastroparesis is frequently associated with diabetes, idiopathic Gastroparesis accounts for the greatest number of cases.

The other market driving factors of Gastroparesis are surgery on the stomach or vagus nerve, anorexia nervosa, use of narcotics that slow gastric contractions, gastro esophageal reflux disease, disorders, such as amyloidosis and scleroderma, Parkinson's disease, metabolic disorders such as hypothyroidism etc.

The global market for Gastroparesis treatment is expected to reach around USD 5,323.62 million by the end of the forecast period and is expected to grow at a CAGR of ~ 3.8 %.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3213

Key Players for Global Gastroparesis Treatment Market: 

Some of the key players in this market are: Medtronic, Kimberly-Clark Corporation, Abbott Laboratories, Salix Pharmaceuticals, Inc., Boston Scientific Corporation, C. R. Bard, Inc., Janssen Global Services, LLC, Cardinal Health, Inc., Alfa Wassermann SPA, Evoke Pharma, Rhythm Pharmaceuticals, Inc. and others.

Intended Audience

Gastroparesis Treatment manufacturers

Gastroparesis Treatment suppliers

Private research laboratories

Research and development (R&D) companies

Market research and consulting service providers

Government research laboratories

Segments:

Global Gastroparesis Treatment market has been segmented on the basis of Gastroparesis type which comprises idiopathic, diabetic, post-surgical and others. On the basis of drug class the market comprises of prokinetic drugs, antiemetics, antidepressants and others. On the basis of other treatment; market is segmented into jejunostomy, gastric electric stimulation (GES) and parenteral nutrition.

Regional Analysis of Global Gastroparesis Treatment Market:

Globally America is the largest market for Gastroparesis treatment. Europe is the second-largest market for Gastroparesis Treatment. Reasons for dominance of the developed regions is the faster market uptake, higher per capita income and excellent reimbursement scenario in these regions. Asia Pacific region is expected to be witness fastest growth and most of it will be led by Japan, China and India.

Segments:

The Gastroparesis Treatment Market is segmented on the basis of product, application and end users. Based on the product, the market has been segmented as diagnostic, therapeutics, medical care and nutrition and wellness and others. Based on application, the market has been segmented into diagnosis and intervention, drug development and usage, cancer genomics and others. Further on the basis of end users the market has been segmented as hospitals, molecular diagnostic laboratories and testing centers, academic institutes, bio and health informatics companies and others.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/3213

Detailed Table of Contents:

Table Of Contents

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s Five Forces Model

4.1.1 Bargaining Power Of Suppliers

4.1.2 Bargaining Power Of Customer

4.1.3 Intensity Of Competitor’s

4.1.4 Threat Of New Entrants

5 Global Gastroparesis Treatment Market, By Gastroparesis Type

5.1 Introduction

5.1.1 Idiopathic

5.1.2 Diabetic

5.1.3 Post-Surgical

5.1.4 Others

...Continued

Send An Enquiry @  https://www.marketresearchfuture.com/enquiry/3213

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact

Company Name: Market Research FutureContact Person: Abhishek Sawant


Email: [email protected]
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com



Source: www.abnewswire.com


Page: 1


Related Keywords:Business,Health & Medicine,Services,U.S,World,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • ChenMed to Invest More Than $200 Million to Bring Affordable Concierge-Style Health Care to Philadelphia Seniors
  • Consuelo M. Alvarez, M.D., MBA, is recognized by Continental Who's Who
  • IV Infusion Pump Accessories Market is poised to register a CAGR of 4.5% by 2025 – Persistence Market Research
  • Effie Chow Qigong Healing System Available On Mediterranean Celebrity Cruise Line Says Sharon Kleyne & Rose Hong
  • The Methuselah Foundation Successfully Closes its Boutique Venture Fund, the Methuselah Fund, Focused on Companies That Can Extend the Healthy Human Lifespan

    Cancer
  • Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients at the International Gynecologic Cancer Society
  • Cleveland Cavaliers' Kevin Love Launches The Kevin Love Fund To Promote Physical And Mental Wellness
  • BioPlus Specialty Pharmacy Announces New President: Mark Montgomery
  • Astellas Promotes Geoff Towle to Vice President of Oncology Marketing at Astellas US
  • Chardan Advises NovellusDX in Cross-Border Biotech Merger
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines